Share Article
Mr. Meyers joined Gilead in 1996 as a regional sales director and has
been the Senior Vice President of North American Commercial Operations
since 2007. In his 20 years at Gilead, Mr. Meyers has been instrumental
in building out the company’s commercial operations in
“Jim has demonstrated a remarkable ability to navigate the complexities
of commercial operations, ensuring we reach diverse audiences with
information about Gilead’s medicines and ultimately that we make those
medicines accessible to people in need,” said
About
Gilead Forward-Looking Statement
This press release includes forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 that are
subject to risks, uncertainties and other factors. These risks,
uncertainties and other factors could cause actual results to differ
materially from those referred to in the forward-looking statements. The
reader is cautioned not to rely on these forward-looking statements.
These and other risks are described in detail in Gilead’s Quarterly
Report on Form 10-Q for the quarter ended
For more information on
View source version on businesswire.com: http://www.businesswire.com/news/home/20161116006551/en/
Source:
Gilead Sciences, Inc.InvestorsSung Lee, 650-524-7792MediaAmy Flood, 650-522-5643
Investors
Jacquie Ross
investors_relations@gilead.com
Media Contact
Meaghan Smith
public_affairs@gilead.com
Other News
Some of the content on this page is not intended for users outside the U.S.